Search clinical trials for: enzalutamide
Total 332 results
-
Nuvation Bio Inc.WithdrawnProstate Cancer | Prostate Neoplasm | Cancer of the Prostate | Prostatic Cancer | Castrate Resistant Prostate Cancer | Cancer of Prostate | Castration Resistant Prostatic Cancer | Castration Resistant Prostatic NeoplasmsUnited States
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstatic NeoplasmsUnited States, Belgium, Canada, Denmark, France, Germany, Romania, United Kingdom
-
PfizerTerminatedMelanoma | Carcinoma, Renal Cell | Breast Neoplasms | Liver Neoplasms | Colorectal Neoplasms | Pancreatic Neoplasms | Mesothelioma | Neoplasms, Squamous Cell | Prostate NeoplasmsUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedEnzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate CancerRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
AstraZenecaParexelCompleted
-
National Cancer Institute (NCI)TerminatedProstate Neoplasms | Metastatic Castration Resistant Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Andreas JosefssonGöteborg University; Umeå University; Sahlgrenska University Hospital, Sweden; Sundsvall... and other collaboratorsTerminated
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Translational Research Center for Medical Innovation...Kagawa UniversityCompleted
-
Jodi Layton, MDEMD SeronoTerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.CompletedProstate Cancer | Prostate Adenocarcinoma | High Risk Prostate CancerUnited States
-
The Netherlands Cancer InstituteCompletedMetastasis | Prostate Cancer MetastaticNetherlands
-
The European Uro-Oncology GroupCentre for Human Drug Research, NetherlandsCompletedProstate Cancer MetastaticNetherlands
-
The European Uro-Oncology GroupCentre for Human Drug Research, NetherlandsCompletedProstate Cancer MetastaticNetherlands
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbCompletedProstate Cancer | Recurrent Prostate Carcinoma | Stage IV Prostate AdenocarcinomaUnited States
-
Astellas Pharma Global Development, Inc.PfizerCompleted
-
Genentech, Inc.CompletedNeoplasmsUnited States, Spain, United Kingdom, France
-
Dana-Farber Cancer InstitutePfizer; Astellas Pharma IncCompletedCastration-resistant Prostate CancerUnited States
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Ontario Clinical Oncology Group (OCOG)Completed
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.Active, not recruitingSalivary CancerUnited States
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
University of California, San FranciscoNational Comprehensive Cancer NetworkTerminatedProstatic Neoplasms | Pelvic NodalUnited States
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Stage I Renal Cell CancerUnited States
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
H. Lee Moffitt Cancer Center and Research InstituteAstellas Pharma IncCompletedPancreatic CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Ann Arbor Stage I Mantle Cell Lymphoma | Ann Arbor Stage II Mantle Cell Lymphoma | Ann Arbor Stage III Mantle Cell Lymphoma | Ann Arbor Stage IV Mantle Cell LymphomaUnited States
-
George Washington UniversityTerminatedProstate AdenocarcinomaUnited States
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Astellas Pharma IncPfizerCompleted
-
University of Colorado, DenverUnited States Department of DefenseCompleted
-
Eli Lilly and CompanySarah Cannon Development InnovationsCompletedProstate Cancer MetastaticUnited States
-
National Cancer Institute (NCI)Terminated
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsCompletedProstate CancerUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Completed
-
Prostate Cancer Clinical Trials ConsortiumUniversity of Chicago; Astellas Pharma IncTerminatedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMayo Clinic; Washington University School of Medicine; Astellas Pharma US, Inc.; University of Southern California and other collaboratorsCompletedHepatocellular CarcinomaUnited States
-
Cedars-Sinai Medical CenterCompletedProstate CancerUnited States
-
Duke UniversityCompleted
-
Astellas Pharma IncPfizerCompletedCastration-resistant Prostate CancerJapan
-
Gilead SciencesTerminatedMetastatic Castrate-Resistant Prostate CancerUnited States
-
MedSIRBayerCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of DefenseCompletedCastration Resistant Metastatic Prostate CancerUnited States
-
Hinova Pharmaceuticals Inc.CompletedMetastatic Castration Resistant Prostate CancerChina
-
BayerCompletedCerebrovascular CirculationUnited Kingdom
-
University of UtahCompleted